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Abstract
Syncytins are envelope genes from endogenous retroviruses, “captured” for a role in pla-
centation. They mediate cell-cell fusion, resulting in the formation of a syncytium (the syncy-
tiotrophoblast) at the fetomaternal interface. These genes have been found in all placental
mammals in which they have been searched for. Cell-cell fusion is also pivotal for muscle
fiber formation and repair, where the myotubes are formed from the fusion of mononucle-
ated myoblasts into large multinucleated structures. Here we show, taking advantage of
mice knocked out for syncytins, that these captured genes contribute to myoblast fusion,
with a >20% reduction in muscle mass, mean muscle fiber area and number of nuclei per
fiber in knocked out mice for one of the two murine syncytin genes. Remarkably, this reduc-
tion is only observed in males, which subsequently show muscle quantitative traits more
similar to those of females. In addition, we show that syncytins also contribute to muscle
repair after cardiotoxin-induced injury, with again a male-specific effect on the rate and
extent of regeneration. Finally, ex vivo experiments carried out on murine myoblasts demon-
strate the direct involvement of syncytins in fusion, with a >40% reduction in fusion index
upon addition of siRNA against both syncytins. Importantly, similar effects are observed
with primary myoblasts from sheep, dog and human, with a 20–40% reduction upon addition
of siRNA against the corresponding syncytins. Altogether, these results show a direct contri-
bution of the fusogenic syncytins to myogenesis, with a demonstrated male-dependence of
the effect in mice, suggesting that these captured genes could be responsible for the mus-
cle sexual dimorphism observed in placental mammals.
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Author Summary
Syncytins are “captured” genes of retroviral origin, corresponding to the fusogenic enve-
lope gene of endogenized retroviruses. They are present in all placental mammals in which
they have been searched for, where they play an essential role in placentation via their cell-
cell fusion activity. Here we show that they also contribute to myoblast fusion and muscle
formation in development and repair after injury, using both in vivo knock-out mouse
models and ex vivo primary myoblast cell cultures from several mammals, including
humans, carnivores and ruminants. Interestingly, the effects observed in mice are sex-
dependent, thus suggesting that the added “collateral” effect of syncytins on myogenesis
could be responsible for the muscle sexual dimorphism observed in placental mammals.
Introduction
Syncytins are “captured” genes of retroviral origin that correspond to the envelope gene of
ancestrally endogenized retroviruses (reviewed in [1]). These genes encode fusogenic proteins
that are involved in the formation by cell-cell fusion of the placental syncytiotrophoblast in
eutherian mammals and marsupials [2–5]. Furthermore, genetically modified mice, knocked
out for their two syncytin genes–i.e. syncytin-A and syncytin-B [6]—proved to be deficient in
placenta development, with altered structures of the materno-fetal interface resulting, in the
case of Syncytin-A, in the death of the embryo at mid-gestation [7, 8]. It thereafter turned out
that syncytins can be found in all placental mammals in which they had been searched for, with
independently captured syncytins found in all major clades of placental mammals, including
the Euarchontoglires (primates, rodents, lagomorpha), Laurasiatherians (ruminants, carni-
vores), Afrotherians (tenrec), and even the marsupials (opossum). This has led to the hypothe-
sis that these genes, which are absolutely required for placentation, as shown by the knock-out
mice experiments, are most likely responsible for the emergence of placental mammals from
egg-laying animals. Analysis of the conservation of these “new” genes clearly indicated that
they have been subjected to purifying selection in the course of evolution, as expected for any
bona fide cellular gene. Of note, cell-cell fusion is a basic phenomenon for all species, from dro-
sophila to humans, where such events are involved in numerous processes including, in addi-
tion to placentation in mammals, macrophage fusion for osteoclast formation, and most
importantly myoblast fusion for myogenesis during development and for muscle regeneration
after injury (reviewed in ref. [9–13]). Although syncytins are essentially expressed in the pla-
centa trophoblast cells, low level expression can be detected in other cells such as fusing macro-
phages [14] and myoblasts [15], and we therefore tested, using genetically modified mice,
whether syncytins could participate in muscle formation, thus revealing a “collateral” effect of
the “primary” capture of these genes for placentation.
Myoblast fusion is a complex and tightly controlled process required for the formation of
the skeletal muscle fibers (reviewed in refs. [9, 10, 16]). The fusion process is highly cell-type
specific to ensure that fusogenic myoblasts do not form syncytia with non-muscle cells. The
molecular mechanisms that coordinate myoblast fusion remain incompletely understood,
although several partners of myoblast fusion have already been identified. These include
numerous proteins involved in cell-cell adhesion, as well as proteins involved in actin and lipid
dynamics that allow cytoskeletal and membrane remodeling for cell fusion. Furthermore, a
muscle-specific membrane protein called myomaker that is transiently expressed during myo-
genesis and is both necessary and sufficient to promote myoblast fusion in vivo and in vitro has
recently been identified [17, 18]. Although this protein alone is not sufficient to induce the
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fusion of non-myoblast cells such as fibroblasts, myomaker is likely to be a major player of the
membrane fusion process; yet its partner (either a receptor or a bona fide fusogenic ligand)
remains to be identified. Altogether, the numerous studies carried out on myoblast fusion have
led to the conclusion that these processes involve numerous partners and pathways. As syncy-
tins have been shown to be bona fide fusogens, we investigated their involvement in the overall
myogenesis process.
Results
Syncytin-B knockout male mice present a delay in muscle development
As previously reported, whereas deletion of both syncytin genes, i.e. syncytin-A and syncytin-B
leads to embryonic lethality, knockout of syncytin-B alone allows for surviving progeny to be
obtained. Yet, syncytin-B null (SynB-/-) neonates display a sex-independent growth retardation
characterized by a reduction of body weight of 18% when compared to wild-type neonates
from the same litter [8]. This difference was attributed to associated placental malformations
and was still apparent in 6–8 week old male mice but absent in female mice [8]. In order to
clarify whether the observed decrease in body weight of male mice could be attributed to a
reduction in muscle mass, we measured, in adult 12 week old mice, both the body weight (Fig
1A and 1B) and the mass of several skeletal muscles, located in the hind limbs of the mouse:
two fast-twitch muscles, i.e. Tibialis Anterior (TA) and Extensor Digitorum Longus (EDL), and
one slow-twitch muscle the Soleus (SOL) (Fig 1C). Measurements were performed on F1 mice,
either wild-type or SynB-/-, from at least four different crosses between heterozygous SynB+/-
mice, in order to minimize possible lineage effects and compare genetically related individuals.
As shown in Fig 1A and 1C, adult SynB-/- and WT female mice show no differences in body
weight and muscle mass (17 wt and 13 SynB-/- females). However, adult SynB-/- male mice
show a significant reduction in body mass (12%; p<0.01, Mann and Whitney test; 16 wt and
16 SynB-/- males). This decrease is associated with a reduction in muscle mass as compared to
wild type male mice (15%; p<0.05, Mann andWhitney test), which is observed independently
of the crossing (S1A Fig). We also quantified, in the corresponding animals, as an internal con-
trol, the mass of two organs (heart and kidney), and the length of two bones (tibia and femur),
with no significant differences seen between SynB-/- and WTmice (Fig 1D). These last results
suggest that the reduction in body weight in adult SynB-/- male mice is mainly due to a decrease
in muscle mass (which accounts for 35–40% of the body weight). In addition, these decreases
appear to affect only skeletal muscles, where fusion processes take place. Altogether these
results suggest that Syncytin-B takes part into muscle development in male mice.
Syncytin-B knockout male mice exhibit a reduction in myofiber size and
myonuclei number per fiber
To better characterize the role of syncytin-B in muscle development, morphological analyses of
SynB-/- and WTmuscles (see scheme in S2 Fig) were performed on cryosections of TA, EDL
and SOL muscles, respectively. We first quantified the cross-sectional area (CSA) of the entire
muscle, which was found to be reduced for the three muscles in SynB-/- males as compared to
WT males (Fig 2A;  p<0.05,  p<0.01, Mann and Whitney test). The alteration in muscle
CSA was observed independently of the crossing (four crosses at least) (S1B Fig). As expected,
in females, which did not show a reduction in muscle mass, no differences in CSA were
observed between SynB-/- and wild-type mice. The number of fibers per muscle and the indi-
vidual myofiber CSA, both parameters that contribute to muscle CSA, were also measured, as
illustrated in Fig 2. Equivalent fiber numbers were observed between SynB-/- and wild-type
Syncytin and Myogenesis
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male mice (Fig 2B), but a significant reduction in myofiber CSA was observed in SynB-/- male
mice (Fig 2C and 2D;  p<0.05,  p<0.01, Mann andWhitney test). The alteration in myofiber
mean area was observed independently of the crossing (three to four crosses) (S1C Fig). Finally,
we quantified the number of myonuclei per fiber, in knockout and wild-type mice (Fig 3).
Transversal sections of the three muscles TA, EDL and SOL were immunolabeled with a dys-
trophin antibody to outline the sarcolemma, and were stained with 4',6'-diamidino-2-phenylin-
dole (DAPI) to visualize the nuclei. Nuclei located inside the dystrophin-labeled sarcolemna
were identified as myonuclei and counted (Fig 3B). Accordingly, a decrease of approximately
30% in the myonuclei number was observed in muscles from SynB-/- male mice as compared
to control males (Fig 3A;  p<0.05,  p<0.01, Mann andWhitney test), strongly suggestive of
a defect in myoblast fusion. This difference was not observed in SynB-/- females in comparison
to wild-type. As variations in nuclear size and shape may affect myonuclear count [19], we
measured the nuclear length of myonuclei on longitudinal sections. No differences were
observed between either WT or SynB-/-, male or female mice (S3A and S3B Fig). As expected,
Fig 1. Phenotype of 12 week old SynB-/- andWTmice. (A) Body weight. (B) Representative WT and SynB-/- male (m) and female (f) mice. (C)
Muscle mass of three skeletal muscles located in the hindlimb, TA (Tibialis Anterior), SOL (Soleus), EDL (Extensor Digitorum Longus). (D) Mass
of heart and kidney, length of tibia and femur. Data are the mean ± SEM (number of mice per sex and per genotype: 13–17 in A, 5–11 inC, 4–7 in
D; * p<0.05, ** p<0.01, Mann andWhitney test).
doi:10.1371/journal.pgen.1006289.g001
Syncytin and Myogenesis
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the resulting number of myonuclei per mm of fiber (S3C–S3E Fig) showed a decrease in mus-
cles from SynB-/- males as compared to control males, whereas no significant differences were
observed in females. Since myoblast fusion and accumulation of myonuclei contribute to mam-
malian myofiber development and growth [20–22] the data also strongly suggest that the
reduced myofiber CSA observed in SynB-/- male mice, which have an unaltered myofiber num-
ber, mainly results from a defect in myoblast fusion to myofibers.
Syncytin-B plays a role during muscle regeneration in male mice
Muscle regeneration is a physiological process that recapitulates, through the differentiation
and fusion of satellite cell descendants, all the phases of myogenesis [16]. We therefore investi-
gated the requirement for syncytin-B during muscle regeneration. We first analyzed, by in situ
hybridization, the expression of syncytin-B upon muscle injury. Muscle injury was induced by
a single injection of cardiotoxin into the TA muscle of 8 week old female and male mice. Injec-
tion of PBS in the contralateral muscle was used as a control. Muscles were collected after 4
Fig 2. Muscle phenotype of 12 week old SynB-/- mice. (A) Cross-sectional area (CSA) of SOL, EDL and TAmuscles (mm2) of WT and
SynB-/- male and female mice. (B) Number of myofibers per muscle section. (C) Myofiber CSA (μm2) in SOL, EDL and TA muscles of WT
and SynB-/- male and female mice. Histological analysis was performed on at least 150 myofibers randomly chosen from three different
tissue sections for each condition. (D) Anti-dystrophin and DAPI labelling of 10 μm sections of optimum cutting temperature (OCT)-frozen
EDL muscles from 12 week old male mice (scale bar: 100 μm). A myofiber (mf) is delineated in white. Data are the mean ± SEM (5–8 mice
analyzed per sex and per genotype; * p<0.05, ** p<0.01, Mann andWhitney test).
doi:10.1371/journal.pgen.1006289.g002
Syncytin and Myogenesis
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days of regeneration (see scheme in Fig 4M). Hematoxylin, eosin and safran staining (HES) of
the muscle sections (Fig 4A), shows normal myofibers after PBS injection, with myonuclei
located at the myofiber periphery. In contrast, following cardiotoxin injection, similar damage
of the muscle section could be observed (delineated by black arrows, Fig 4D and 4G) in male
and female mice. During muscle regeneration, the damaged myofibers are destroyed and
replaced by small newly centro-nucleated fibers, typically representative of muscle regenera-
tion. These new fibers observed in male as in female mice, are illustrated in the enlarged Fig 4J
for a male mouse. Specific digoxigenin-labeled antisense probes were then synthetized for the
detection of syncytin-B, and the corresponding sense probes were used as negative controls. As
further shown in Fig 4E and 4K, labeling was only observed with the antisense probe for syncy-
tin-B, and only in males. Closer examination of the labeling further shows that it is restricted to
regions of muscle regeneration (Fig 4D and 4E) where myofibers are centro-nucleated (Fig 4J
and 4K). In situ hybridization of syncytin-B shows conclusively that this gene is expressed in
the regenerative muscle in males, strongly suggesting that the encoded protein could play a role
in this process specifically in males.
To characterize further the role of the Syncytin-B protein in this process, SynB-/- male and
female mice (as well as control wild-type mice) were analyzed after cardiotoxin injection as
above, and muscle regeneration was quantified at day 14. Histological sections of the muscle
fibers were performed as above, and the mean myofiber CSAmeasured. As illustrated in Fig 4N,
quantification of the myofiber CSA in SynB-/- male mice in comparison to wild-type shows a
delay at day 14, suggesting that Syncytin-B plays a role during muscle regeneration (Fig 4N;
p<0.05, Mann andWhitney test) after cardiotoxin treatment. In the case of female mice, no dif-
ferences could be detected in the myofiber CSA between SynB-/- and wild-type, suggesting that
Syncytin-B plays a role during muscle regeneration also in a sex-dependent manner (Fig 4N).
Syncytin-A and -B are involved in myoblast fusion
To characterize further the role of the syncytin genes in myoblast fusion, we isolated mouse pri-
mary satellite cells and quantified the expression of both syncytin-A and–B in proliferating
Fig 3. Myonuclei number in 12 week old SynB-/- mice. (A) Quantification of the myonuclei number per 100 fibers
in SOL, EDL and TA muscles of WT and SynB-/- male and female mice. The number of myonuclei was estimated by
analyzing at least 300 myofibers for each condition. Data are the mean ± SEM (4–6 mice analyzed per sex and per
genotype; * p<0.05, ** p<0.01, Mann andWhitney test). (B) Nuclei corresponding to myonuclei (white arrow) are
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myoblasts, as well as during the process of cell differentiation and fusion (day 0, day 2 and day
4, see Fig 5A). Both genes were detected by quantitative RT-PCR and were found to be upregu-
lated after 2–4 days of myogenic differentiation and myoblast fusion (when myotubes could be
clearly observed), whereas the level of the housekeeping gene remained stable. These data sug-
gest that both syncytin genes could be involved in this process. To investigate further their role
in myoblast fusion, we knocked-down syncytin-A and–B expression by RNA-mediated inter-
ference (Fig 5B). After two days of differentiation, silencing of both syncytin genes resulted in a
very significant inhibition of myoblast fusion as illustrated in Fig 5C, with a close to 50%
decrease in the fusion index (Fig 5D). Analysis of the nuclei distribution in myoblast cells
revealed a significantly higher number of mononucleated cells in cells transfected with either
Fig 4. Impact of syncytin-B duringmuscle regeneration. (A-L) In situ hybridization of syncytin-B during muscle regeneration following
cardiotoxin injury. Mice were injected with PBS or with cardiotoxin (Ctx) 4 days before muscle examination. Sections were stained with HES
(A, D,G and J) and were hybridized with a sense probe (C, F, I and L) or with an antisense probe specific of syncytin-B (B, E, H and K). The
regenerative zone of the muscle section is indicated by black arrows (D, E, G andH). The regenerative zone is composed of small centro-
nucleated fibers, indicated by asterisks (J). (A-I) scale bar 500 μm; (J-L) scale bar 50 μm. (M, N) 8 week old WT and SynB-/- male and
female mice were injected with PBS (control) or cardiotoxin (Ctx) and muscle regeneration was characterized at day 14. Histological
analysis was performed on at least 150 myofibers randomly chosen from three different tissue sections per condition. Data are the
mean ± SEM (4–5 mice analyzed per sex and per genotype; * p<0.05, Mann andWhitney test). When measuring myofiber mean area of
SynB-/- in comparison to wild-type male mice after Ctx treatment, a delay is clearly visible at day 14 of regeneration. Of note, the difference
observed after control PBS injection is consistent with that observed in Fig 2C for uninjured animals.
doi:10.1371/journal.pgen.1006289.g004
Syncytin and Myogenesis
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syncytin-A or syncytin-B siRNAs in comparison to cells transfected with a control siRNA (Fig
5E;  p<0.05,  p<0.01, Student’s t-test). In addition, a significantly higher number of cells
with>4 nuclei was observed in control cells in comparison to cells transfected with syncytin-A
or syncytin-B siRNAs, with no myotube containing>8 nuclei in both cases. Combination of
the two syncytin siRNAs had no additive effect (Fig 5D) suggesting that, at least ex vivo, the
two syncytins are acting on similar–and most probably interactive- steps of myoblast fusion. Of
note, reduction in fusion index mediated by siRNA targeted to syncytins remains smaller than
that with a siRNA targeted to themyomaker gene (ref. 17 and Fig 5D), consistent with the
notion that syncytins are only “add-on” contributors to the basal fusogenic activity associated
with the non-syncytin genes. Yet both syncytins are able to trigger myoblast cell-cell fusion.
This is illustrated in Fig 6, where transfection of C2C12 myoblasts with expression vectors for
either syncytin-A or syncytin-B clearly triggered the fusion of myoblasts in their proliferative
state (Fig 6A), and also enhanced the fusion normally triggered upon differentiation of the cells
(Fig 6B and 6C). Altogether, the ex vivo data corroborate the in vivo data on syncytin-B, and
further suggest that syncytin-A could also contribute to myoblast fusion.
Fig 5. Murine syncytin expression and impact of their knockdown onmyoblast cell-cell fusion ex vivo. Primary myoblast cells were
transfected with control siRNA (si cont) or siRNAs specifically designed against syncytin-B (si synB),–A (si synA) or myomaker (si
myomaker), and differentiation was induced 2 days later. Following two days of differentiation, cells were fixed in 4% PFA, stained with an
anti-desmin antibody (muscle cell marker), and nuclei were counterstained with DAPI. (A) Level of expression of syncytin-B and -A
(arbitrary units, A. U.) during myoblast fusion in murine primary myoblasts, either actively proliferating (P: proliferating non confluent cells,
D0: proliferative confluent cells), or in differentiation and fusion (D2 to D4), as analyzed by quantitative RT-PCR. All quantifications were
normalized by RPL0, and the fold-change in gene expression expressed relative to the values of proliferating myoblasts, arbitrarily settled
to one. (B) Efficiency of siRNA knockdownmeasured by quantitative RT-PCR. (C) Representative images of desmin- and DAPI-labelled
myoblast cells transfected with control, syncytin-B or syncytin-A siRNAs. Representative myotubes are indicated by white arrows whereas
white triangles correspond to mononucleated myoblast cells. (D) Fusion index (number of nuclei in cells with2 nuclei per total number of
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The role of syncytin genes in myoblast fusion extends to other mammals
To determine if the effects observed in the mouse can be extrapolated to other placental mam-
mals, we established primary cultures of myoblasts from the muscles of mammals where the
cognate syncytins have been characterized. Accordingly, we obtained viable and fusion-prone
myoblasts from human (primate) (Fig 7A), sheep (ruminant) (Fig 7B) and dog (carnivore) (Fig
7C). As illustrated in Fig 7, left panels, induction of each cognate syncytin gene could be
observed during the process of cell differentiation and fusion, as similarly observed for the
murine myoblasts (Fig 5), whereas the level of the housekeeping genes remained stable. Experi-
ments were then carried out as above for the mouse myoblast cells, but using siRNAs specific
for each of the corresponding syncytins (i.e., syncytin-1 and -2, syncytin-Rum1 and syncytin-
Car1 respectively). Accordingly, transfection of the cells with siRNA specific for each cognate
syncytin clearly resulted in a significant (>20%) reduction in the measured fusion index (Fig 7,
middle panels), also visible in the reduction in the number of large myotubes (Fig 7, right
panels).
Fig 6. Impact of murine syncytins andmyomaker overexpression onmyoblast cell-cell fusion ex vivo. C2C12myoblasts were co-
transfected with an empty (cont), syncytin-A (synA),–B (synB) or myomaker expression vector, supplemented with a GFP expression
vector. Differentiation was induced 2 days later (D0). Cells were fixed at D0 or after four days of differentiation (D4) in 4% PFA, stained with
an anti-desmin antibody (muscle cell marker), and nuclei were counterstained with DAPI. (A) The fusion index at D0 was calculated as the
percentage of nuclei in GFP-positive cells with at least 2 nuclei. (B) The fusion index at D4 of differentiation was calculated as the
percentage of nuclei in desmin-positive cells with at least 2 nuclei. (C) Representative images of desmin- and DAPI-labelled cells
transfected with the control, syncytin-A, syncytin-B or myomaker vectors at D4. Data are the mean ± SEM (three independent experiments;
* p<0.05, ** p<0.01, Student’s t-test).
doi:10.1371/journal.pgen.1006289.g006
Syncytin and Myogenesis
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Discussion
In this study, we address for the first time the role of the two murine syncytin genes (syncytin-A
and–B, in myogenesis, both in vivo using a syncytin-B knockout mouse model, and ex vivo
using primary cell cultures derived from isolated muscle satellite cells. We show that both syn-
cytin genes are expressed ex vivo during the fusion of myoblast cells and that syncytin-B is
expressed in regenerative fibers in vivo following cardiotoxin injury. Using syncytin-A and–B
siRNAs, we demonstrate ex vivo that both syncytin genes contribute to myoblast cell fusion. In
addition, using a knockout mouse model for syncytin-B, we show that impairment of syncytin-
B leads to a reduction in muscle mass, that largely contributes to the observed reduction in
body weight. This effect is male-specific, being not observed in females, that provide a clear-cut
internal control. This decreased mass correlates with an observed reduction in several muscle
parameters, including the muscle cross-sectional area, the individual myofiber cross-sectional
Fig 7. Role of syncytins in myoblasts from human, sheep and dog. Left panels: level of expression of the human syncytin-1 and -2 (A),
the ruminant syncytin-Rum1 (B) and the carnivore syncytin-Car1 (C) genes (arbitrary units, A. U.) during proliferation and differentiation of
primary myoblasts from human, sheep and dog, as determined by quantitative RT-PCR and normalized by the beta2-microglobulin, SDHA
and PPIA housekeeping genes, respectively; the fold-change in gene expression was expressed relative to the values of proliferating
myoblasts, arbitrarily settled to one. Middle and right panels: impact of siRNA-mediated knockdown of syncytins on ex vivo cell-cell fusion of
myoblasts from human, sheep and dog, respectively. Cells were transfected with siRNA (control or specifically designed against the
corresponding syncytins), and differentiation induced 2 days later. Following 2 days of differentiation, cells were fixed in 4% PFA, stained
with an anti-desmin antibody (muscle cell marker), and nuclei were counterstained with DAPI. The fusion index (number of nuclei in cells
with >2 nuclei per total number of nuclei) was determined (middle panels). Representative images of desmin-immunolabeled and DAPI-
stained myoblasts transfected with either control or syncytin-specific siRNAs, respectively, are shown (right panels). Data are the
mean ± SEM (at least three independent experiments; * p<0.05, ** p<0.01, Student’s t-test).
doi:10.1371/journal.pgen.1006289.g007
Syncytin and Myogenesis
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area, and most importantly the number of nuclei per muscle fiber. Furthermore, we show that
the total number of fibers per muscle is not altered in syncytin-B knockout mice, suggesting
that syncytin-B activity is essentially involved in myofiber growth and not in the initiation of
myogenesis. The reduction in the number of nuclei per myofiber would be consistent with
such a role and with the fusogenic activity demonstrated in the ex vivo experiments. Finally,
using a model of muscle regeneration after injury by cardiotoxin injection, we show that
impairment of syncytin-B results in a delay in muscle regeneration, again only observed in
males, consistent with the specific induction of syncytin-B expression observed in wild-type
regenerating male myofibers. To summarize, the present data indicate that syncytin-B (and
possibly syncytin-A, see below), participates in myoblast fusion, and contributes to muscle
growth and regeneration in the mouse, in a sex-dependent manner.
This series of results raise several issues. One of the most obvious questions is related to the
function of syncytin-A. Indeed, our cell fusion assays performed in C2C12 cells and in primary
myoblasts strongly suggest that both syncytins have closely related activities, with similar effects
of synA and synB siRNAs on myoblast fusion. This would fit with the known properties of
these two genes, which have very similar activities at the placental level, each one being
involved in the formation of a definite syncytiotrophoblast layer at the feto-maternal interface
[8]. However a definitive characterization of the role of syncytin-A in myogenesis will require
its conditional knock-out, specifically in the muscle, because homozygous null placentae are
embryonic lethal. Along these lines, a mouse model obtained by crossing a lox-syncytin-A
knock-in mouse with a Pax7-Cre-ERT2 mouse [23] is being developed, which should allow to
generate a muscle-specific knock-out of syncytin-A, thus circumventing the detrimental effect
of syncytin-A inactivation in placentation.
Another important issue concerns the generality of the contribution of syncytin genes to
myogenesis. We have clearly demonstrated that not only the murine syncytins but also syncytins
from ruminants, carnivores and humans contribute to myoblast fusion, at least in ex vivo assays.
Similar conclusions were reached for human myoblasts [15, 24], where either siRNAs or an anti-
body targeting Syncytin-1 inhibit cell fusion of cultured myoblasts. Although the physiological
relevance of such assays can be questioned, they nevertheless strongly suggest that the effects
observed for the murine genes might extend to all species possessing a syncytin. Indeed, in the
present study, we tested all four species with identified syncytins for which we succeeded in
establishing primary myoblasts prone to cell fusion (we could not isolate myoblasts from the
rabbit, in which we had previously characterized syncytin-Ory1, [25]), and in all four cases the
results were identical, with inhibition of fusion by the corresponding syncytin gene-specific
siRNA. It is therefore tempting to speculate that syncytins, which have been captured in all pla-
cental mammals most probably primarily for their placental function, all contribute, as observed
here in vivo in the mouse, to myogenesis. However, this hypothesis will remain difficult to dem-
onstrate or invalidate unless, for instance, myoblast fusion is found to be independent of syncy-
tin, in a species where the gene is present. At the molecular level, the myoblast fusion process is
still an unresolved question, although it is clear that it involves a wide panel of genes (for a
review see ref. [9, 12]). Some have been shown to be required for myogenesis in vivo (via the use
of KOmice), such as the recently identifiedmyomaker gene [17, 18], the contributing galectin
gene [26], cell adhesion/signal transduction proteins [27] or a series of actin cytoskeletal remod-
eling factors (reviewed in [9, 28]). Yet, in all cases none of the identified genes are truly autono-
mous fusogens, but rather seem to be either co-factors, yet absolutely required for myogenesis,
or partners of a still to be identified “universal” fusogen. Our data on myomaker transfection of
C2C12 myoblasts (Fig 6) do not provide evidence for a direct fusogenic activity in the proliferat-
ing state (at variance with syncytin A and B). This result is consistent either with myomaker not
being a bona fide fusogen or its fusion partner only being expressed upon myoblast
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differentiation. In the case of the presently identified syncytins, these are bona fide fusogens, a
function inherited from the envelope gene of the ancestral retroviruses from which they were
captured. Their contribution to myoblast fusion, as well as to cytotrophoblast or macrophage
fusion, could in that case be directly due to their fusogenic activities.
An additional important question arises from the unexpected result on the sex-dependent
effect of syncytin-B in vivo, in myogenesis after birth and muscle regeneration after injury. The
data clearly indicate that the syncytin-B effect is essentially an “add-on” specific to the male,
not taking place in the female, and resulting in an increased number of nuclei per muscle fiber
(consequently associated with an increased muscle mass) and an increased rate of muscle
regeneration after injury. Then a question arises as to the molecular origin of this uncovered
male-dependence. Among the possible mechanisms, a hormone-dependent regulation of syn-
cytin expression would of course fit the data, and could be analyzed by searching for binding
sites within the syncytin gene promoter/enhancer for hormone–dependent factors. Along these
lines, it is clear that testosterone and the androgen receptor (AR) would be appropriate effec-
tors, which could be tested by hormone injection to wild-type mice, with or without prior cas-
tration, or even in mice knocked-out for the AR gene [29]. It is also possible that factors known
to act as transcription factors in the placenta (among others GCM1 [30, 31]) could also act as
syncytin activators in the muscle. Experiments are now in progress to tentatively elucidate
these points. It is also noteworthy that testosterone and/or sustained physical activity (the latter
known to generate microlesion-and-repair cycles) have been reported to result in muscle mass
increase [24, 32–34], with, in some cases, indications for an increase in myonuclei number per
fiber [35, 36]. Moreover, one of these studies shows that long-term endurance exercise in male
humans results in an increase in Syncytin-1 expression, among other genes, in muscle biopsies
[24]. It will be interesting to carry out a similar study on female humans to determine whether
syncytin-1 induction is male-specific, or not. Indeed, such sex-specific effects could be a hint
for a generalized male-dependence of syncytin expression and role in myogenesis among pla-
cental mammals. If so, it is likely that syncytins could then be responsible for the muscle sexual
dimorphism observed in mammals, where in most cases the male has a higher body and muscle
mass than the female.
To conclude, we propose as a working model that syncytins have been captured primarily as
a placental gene, but that some expression in the muscle is taking place (possibly as a conse-
quence of regulatory processes and transcription factors shared by placenta and muscle), and
that a “collateral” effect of the capture of such genes -with a clear-cut fusogenic activity- is an
add-on contribution to myogenesis in males of placental mammals.
Methods
Animal model, ethical agreement
Targeted mutagenesis of syncytin-B gene, located on chromosome 14, was described previously
[8]. Briefly, the mouse syncytin-B ORF (carried by a single 1.8-kb exon) was deleted by homol-
ogous recombination using a strategy based on the Cre/LoxP recombination system for gener-
ating KO mice. Male and female mice were on a mixed 129/Sv C57BL/6 background. They
were housed under controlled conditions at 24°C, and were allowed free access to food and
water in full compliance with the French government animal welfare policy. All the experi-
ments were approved by the Ethics Committee of the Gustave Roussy Institute.
Experimentally induced muscle regeneration
Before manipulations mice were anaesthetized with an intraperitoneal injection of 0.1 ml per
10 g body weight of a solution containing 1 mg/ml xylazine (Bayer) and 10 mg/ml ketamine
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(Merial) per mouse. Then, to induce muscle injury, 35 μl of Cardiotoxin (Ctx) (12 μM;
Latoxan) were injected in a single injection into Tibialis Anterior (TA) muscle of 8 week old
mice. Muscle regeneration was followed at different times depending on the experiments.
Histological and immunofluorescence analyses
Mouse Tibialis anterior (TA), Extensor Digitorum Longus (EDL) and Soleus (SOL) muscles
were dissected, weighed and frozen in isopentane/liquid nitrogen baths. Cryopreserved tissues
were then cut in 10 μm cryosections. Cryosections were cut in the same central region of the
muscle for all analyzed animals. Muscle cryosections were fixed in 4% paraformaldehyde on
ice for 8 min. Tissue sections were then saturated with 5% Goat serum 2% BSA solution for 30
min. Overnight immunolabeling for dystrophin (Leica Biosystems) and laminin (Sigma) was
then performed at 4°C. Nuclei were counterstained with 4',6'-diamidino-2-phenylindole
(DAPI) for 15 min at room temperature. Myofiber cross-sectional area (CSA) was measured
from stained slides from randomly chosen fields using the ImageJ software (at least 150 myofi-
bers were measured per condition).
In situ hybridization (ISH)
Freshly collected muscles were fixed in 4% (wt/vol) paraformaldehyde and embedded in paraf-
fin. Serial sections (7 μm) were used for ISH. For the syncytin-B gene, three PCR-amplified syn-
cytin-B fragments of 414, 511, and 370 bp, respectively (primers listed in S1 Table) were cloned
into pGEM-T Easy (Promega). In vitro synthesis of the antisense and sense riboprobes was per-
formed with SP6 or T7 RNA polymerase and digoxigenin 11-UTP (Roche Applied Science)
after cDNA template amplification. Sections were processed, hybridized at 42°C overnight with
the pooled riboprobes, and incubated further overnight at 4°C with alkaline phosphatase-con-
jugated anti-digoxigenin antibody Fab fragments (Roche Applied Science). Staining was
achieved with the nitroblue tetrazolium (NT) and 5-bromo-4-chloro-3-indolyl phosphate
(BCIP) phosphatase alkaline substrates as indicated by the manufacturer (Roche Applied
Science).
Primary muscle cell culture and fusion assay
Mouse primary myoblasts (female mice) were isolated from TA muscles of 4 week old mice by
enzymatic digestion as described [37]. Myoblasts were grown on collagen-coated dishes in
Ham’s F10 (Life technologies) growth medium supplemented with 20% fetal bovine serum
(FBS), bFGF (10 ng/ml, Invitrogen), penicillin (100 U/ml) and streptomycin (100 mg/ml). For
differentiation, myoblasts were plated at 105 cells per well in collagen-coated 24-well dishes
and differentiation was induced by switching the growth medium to the differentiation
medium DMEM (Life technologies) with 2% horse serum (Biowest) for different times, the day
of the induction being referred to as D0.
Dog (male) and sheep (female) myoblasts were obtained from biopsies of biceps femoris.
The biopsy was cut into small pieces, treated with collagenase (Worthington; 5 ml of collage-
nase per g of tissue) and incubated for 1 h at 37°C. Using a syringe and 18G needle, the mix
was dissociated and filtered sequentially through 100 and 40 μm sieves. After centrifugation,
the cellular pellet was suspended and in the case of dog myoblasts, cells were seeded in Myo1
medium (Hyclone) containing 20% FBS, gentamycin (25 μg/ml, Sigma), bFGF (10 ng/ml, Invi-
trogen) and dexamethasone (1 μM, Mylan). Sheep myoblasts were cultivated on collagen-
coated dishes in DMEMmedium (Life technologies) with 20% FBS, bFGF (10 ng/ml, Invitro-
gen), penicillin (100 U/ml) and streptomycin (100 mg/ml). For differentiation, growth medium
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was replaced with DMEMmedium (Life technologies) supplemented with 2% horse serum
(Life technologies).
Primary human myoblasts (female) were cultivated in proliferation medium (4 vol. of
DMEM, 1 vol. of 199 medium, 20% FBS, gentamycin (50 mg/ml)). Differentiation was induced
by replacing the proliferation medium by DMEM supplemented with insulin (10 mg/ml).
For desmin immunolabeling, cells were fixed for 10 min with 4% formaldehyde and rinsed
with PBS. Cells were permeabilized for 10 min with PBS-0.1% Triton (Sigma) and blocked with
PBS-5% BSA (Sigma) for 45 min before incubation with antibodies. Primary mouse anti-des-
min anti-human antibodies (clone D33, Dako) were incubated overnight at 4°C and revealed
using secondary Alexa 488 goat anti-mouse antibodies (life technologies) for 1h. Nuclei were
stained with DAPI (4’,6’ diamidino-2-phenylindol) for 15 min at room temperature.
The fusion index was calculated as the number of nuclei within cells with2 nuclei at day 3
of differentiation (at least 600 nuclei were counted for each condition).
RNA interference
RNA interference was performed using Lipofectamine RNAi-MAX reagent (Invitrogen)
according to the manufacturer recommendations. Cells were transfected 2 days before induc-
tion of differentiation. All siRNAs, including the siRNA control oligonucleotides, were synthe-
sized by Dharmacon or Eurogentec. SiRNA sequences are listed in S1 Table.
C2C12 cell culture
The C2C12 mouse myoblast cell line (ATCC: CRL1772) (female mice) was grown in DMEM
(Dulbecco’s Modified Eagle medium, life technologies) supplemented with 10% fetal calf
serum (FCS), 100 U/ml penicillin and 100 μg/ml streptomycin. Differentiation was induced by
switching the growth medium to differentiation medium (DMEM with 2% horse serum (Bio-
west)) for four days.
Plasmids and cell transfection
The GFP expression vector peGFP-C3 was purchased from BD Biosciences and the murine
myomaker gene in pCMV-SPORT6.1 from Dharmacon. The control (phCMV-none) and syn-
cytin-A and–B expression vectors were previously described [6]. Transfection of the C2C12
cells was performed using Lipofectamine LTX (ThermoFischer) according to the manufactur-
er’s protocol.
Quantitative real-time RT-PCR
Total RNAs were extracted from mouse, sheep and human myoblast cells using Trizol accord-
ing to the manufacturer’s instructions (Sigma Aldrich). Total RNAs were extracted from dog
myoblasts using the nucleospin RNA XS kit (Macherey Nagel) according to the manufacturer
instructions. The amount of extracted RNAs was evaluated using a NanoDrop spectrophotom-
eter (Thermo Scientific, Wilmington, USA). Syncytin mRNA expression was determined by
Real-time RT-PCR (RT-qPCR). Reverse transcription was performed on 500 ng of DNase-
treated RNAs (Ambion) according to the manufacturer’s instructions. Quantitative PCR was
performed on 5 μL of diluted (1:5) cDNA in a final volume of 25 μL using the SYBR-Green
PCRMaster Mix (Applied Biosystems) in an ABI PRISM 7000 sequence detection system. The
parameters used were as follows: 2 min incubation at 50°C, 5 min at 95°C, followed by 40 cycles
of repeated incubations at 95°C for 10 s and 60°C for 30 s. For each cDNA sample, duplicates
were analyzed and data normalized to the housekeeping genes listed in S1 Table.
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Statistical analysis
Histological analysis of the muscle phenotype in 12 week old mice and the muscle regeneration
in 8 week old mice was performed on at least 150 myofibers randomly chosen from three dif-
ferent tissue sections. The number of myonuclei was estimated by counting the number of
myonuclei in at least 300 myofibers randomly chosen from three different tissue sections per
condition. Statistical analyses were performed using the Mann-Whitney test. A p value<0.05
was considered as significant ( p<0.05,  p<0.01). When the number of samples was<4, Stu-
dent’s t-test was used and differences were considered significant when p<0.05 ( p<0.05, 
p<0.01). For the ex vivo fusion assays, according to the number of samples, a Mann-Whitney
test (n = 4, for mouse and sheep myoblast cells) or a Student’s t-test (n = 3, for C2C12, human
and dog myoblast cells) was used and differences were considered significant when p<0.05 (
p<0.05,  p<0.01).
Supporting Information
S1 Fig. Muscle mass, muscle CSA and myofiber area of individual 12 week old SynB-/- and
WTmice with mention of the cross from which they originate. Individual EDL muscle mass
(A), muscle CSA (B) and myofiber area (C) from wild-type (+/+) and SynB KO (-/-), male (m)
and female (f) mice. The crosses from which the mice originate were labelled by 4 to 5 different
markers (blue square, green triangle, yellow circle, dark blue cross, red star). The values repre-
sented by the same marker in WT and SynB KOmice in the same graph correspond to that of
individual mice from the same cross. The mean muscle mass, muscle CSA and myofiber area
are indicated by horizontal black lines.
(TIF)
S2 Fig. Simplified scheme of skeletal muscle structure.
(TIF)
S3 Fig. Myonuclear length and number of myonuclei per mm of myofiber in 12 week old
SynB-/- mice. (A) Measure of the average myonuclear length of TA muscles fromWT (+/+)
and SynB-/- (-/-), male (m) and female (f) mice. Data are the mean ± SEM (at least 60 myonu-
clei measured for each type) (B) Anti-dystrophin and DAPI labelling of 10 μm longitudinal sec-
tions of optimum cutting temperature (OCT)-frozen TA muscles from 12 week old WT and
SynB-/- male mice (scale bar: 10 μm). (C-E) Quantification of the myonuclei number per mm
of fiber length in SOL, EDL and TA muscles of WT and SynB-/- male and female mice. Data
are the mean ± SEM (4–6 mice analyzed per sex and per genotype;  p<0.05,  p<0.01, Mann
andWhitney test).
(TIF)
S1 Table. List of primers.
(DOCX)
S1 File. Supplementary Methods.
(DOCX)
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